|
Monday, March 22 — 8:00 AM — Thurgood Northeast
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section D - Gynecologic Pathology
Chaired By: Robert Soslow and Marisa Nucci
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Predictors of Adverse Outcome in Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)
(1093)
M Gupta, BJ Quade, MR Nucci. - Brigham &#Women's Hospital, Boston, MA.
|  Add |
| 8:15 |
Late Recurring Uterine Smooth Muscle Tumors Constitute a Heterogeneous Collection of Leiomyosarcomas and STUMPs
(1201)
E Veras, O Zivanovic, L Jacks, M Hensley, R Soslow. - Memorial Sloan-Kettering Cancer Center, New York, NY.
| Add |
| 8:30 |
Cell Cycle Regulatory Markers in Uterine Atypical Leiomyoma, Cellular Leiomyoma, STUMP and Leiomyosarcoma: Immunohistochemical Study of 74 Cases with Clinical Follow-Up
(1142)
AM Mills, A Ly, BL Balzer, MR Hendrickson, RL Kempson, JK McKenney, TA Longacre. - Stanford University, Stanford, CA.
| Add |
| 8:45 |
"Low Grade Uterine LMS" a Clinically Favorable, but Heterogeneous Group of Mesenchymal Tumors
(1186)
R Soslow, O Zivanovic, L Jacks, M Hensley, E Veras. - Memorial Sloan-Kettering Cancer Center, New York, NY.
| Add |
| 9:00 |
Clinicopathological and Immunohistochemical Study in 148 Uterine Sarcomas: Bcl-2 and Proliferative Markers Identify Different Prognostic Groups of Uterine Leiomyosarcomas
(1070)
E D'Angelo, R Ali, I Espinosa, CB Gilks, M Van de Rijn, C-G Lee, J Prat. - Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain; University of British Columbia, Vancouver, BC, Canada; Stanford University Medical Center, Stanford, CA.
| Add |
| 9:15 |
Endometrial Sarcomas, How Many Categories Are Out There? A Tissue Microarray and Immunohistochemistry Study of 33 Cases
(1167)
M Rouzbahman, G Rasty, F Azimi, BA Clarke, H Begley, PA Shaw. - University Health Network, Toronto, ON, Canada.
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
HPV DNA Testing: Is it Used Appropriately?
(1071)
S Davion, E Lucas, A Kemp, R Nayar. - Northwestern University, Chicago, IL.
| Add |
| 11:15 |
Correlation of the Hybrid Capture II High-Risk HPV DNA Test Chemiluminescense Intensity from Cervical Samples with Follow-Up Histologic Results: A Cytologic/Histologic Review of 367 Cases
(1118)
SM Knoepp, DL Kuebler, DC Wilbur. - University of Michigan, Ann Arbor, MI; Massachusetts General Hospital/Harvard Medical School, Boston, MA.
| Add |
| 11:30 |
Histopathologic Follow-Up of Women with Post-hysterectomy LSIL Vaginal Paps and High Risk HPV Testing
(1047)
M Bansal, RM Austin, CZ Zhao. - University of Pittsburgh Medical Center, Pittsburgh, PA.
| Add |
| 11:45 |
Cytological Results and Clinical Findings Associated with 265 Histopathological Diagnoses of Cervical Glandular Neoplasia: Results of 10 Years
(1214)
C Zhao, RM Austin. - Magee Womens Hospital, UPMC, Pittsburgh.
| Add |
|
|
